Bunce C M, French P J, Durham J, Stockley R A, Michell R H, Brown G
Department of Immunology, University of Birmingham, Edgbaston, UK.
Leukemia. 1994 Apr;8(4):595-604.
We have confirmed previous observations that HL60 cells treated with a combination of 10 nM retinoic acid (RA), and 30 ng/ml granulocyte colony-stimulating factor (G-CSF) differentiate efficiently towards neutrophils, as characterized by their growth arrest and acquisition of phagocytic ability. Such low concentrations of RA alone provoked only a small proportion of HL60 cells to differentiate, and G-CSF alone provoked no differentiation. In the presence of 30 microM indomethacin (an inhibitor of the enzyme cyclooxygenase that catalyses the first step of prostanoid synthesis), the onset of differentiation provoked by RA plus G-CSF was more rapid, but the final proportion of mature cells was unchanged. Indomethacin also potentiated the growth arrest and differentiation of cells in response to 10 nM RA alone. Although the potentiating effect of indomethacin on RA-induced differentiation occurred at several indomethacin and RA concentrations, it was only apparent when the RA concentration used was alone sufficient to induce a small proportion of cells to differentiate. Indomethacin shifted the G-CSF dose-response curve of cells treated with 10 nM RA to lower G-CSF concentrations. 1 alpha,25-dihydroxy vitamin D3 (VitD3) induces HL60 cells to differentiate to monocytes and indomethacin also potentiated the differentiation of HL60 cells in response to low doses of VitD3 5,8,11-eicosatriynoic acid, an inhibitor of 5-lipoxygenase and 12-lipoxygenase, neither potentiated neutrophil differentiation of HL60 cells, nor prevented indomethacin potentiation of the differentiation of RA-primed cells. Treatment of cells with dexamethasone, a steroid whose effects include inhibition of arachidonate mobilization by phospholipase A2, potentiated RA-primed neutrophil differentiation in a manner similar to indomethacin. These observations suggest that an arachidonate metabolite formed downstream of cyclooxygenase suppresses differentiation of HL60 cells both to neutrophils and monocytes, probably by inhibiting some event essential to commitment to differentiation.
我们证实了之前的观察结果,即经10 nM视黄酸(RA)与30 ng/ml粒细胞集落刺激因子(G-CSF)联合处理的HL60细胞能高效地向中性粒细胞分化,其特征为生长停滞和获得吞噬能力。单独使用如此低浓度的RA仅能促使一小部分HL60细胞分化,而单独使用G-CSF则不会引发分化。在存在30 μM吲哚美辛(一种催化前列腺素合成第一步的环氧合酶抑制剂)的情况下,RA加G-CSF引发的分化起始更快,但成熟细胞的最终比例未变。吲哚美辛还增强了单独使用10 nM RA时细胞的生长停滞和分化。尽管吲哚美辛对RA诱导分化的增强作用在多个吲哚美辛和RA浓度下均有发生,但仅在所用RA浓度单独足以诱导一小部分细胞分化时才明显。吲哚美辛将用10 nM RA处理的细胞的G-CSF剂量反应曲线向更低的G-CSF浓度方向移动。1α,25 - 二羟基维生素D3(VitD3)诱导HL60细胞向单核细胞分化,吲哚美辛也增强了HL60细胞对低剂量VitD3的分化反应。5,8,11 - 二十碳三烯酸,一种5 - 脂氧合酶和12 - 脂氧合酶的抑制剂,既没有增强HL60细胞向中性粒细胞的分化,也没有阻止吲哚美辛对RA预处理细胞分化的增强作用。用地塞米松处理细胞,地塞米松是一种类固醇,其作用包括抑制磷脂酶A2介导的花生四烯酸动员,其增强RA预处理的中性粒细胞分化的方式与吲哚美辛相似。这些观察结果表明,在环氧合酶下游形成的一种花生四烯酸代谢产物可能通过抑制分化所必需的某些事件,抑制HL60细胞向中性粒细胞和单核细胞的分化。